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Abstract
Background: Illiteracy, a universal problem, limits the utilization of the most widely used short cognitive tests. Our objective
was to assess and compare the effectiveness and cost for cognitive impairment (CI) and dementia (DEM) screening of three
short cognitive tests applicable to illiterates.
Methods: Phase III diagnostic test evaluation study was performed during one year in four Primary Care centers,
prospectively including individuals with suspicion of CI or DEM. All underwent the Eurotest, Memory Alteration Test (M@T),
and Phototest, applied in a balanced manner. Clinical, functional, and cognitive studies were independently performed in a
blinded fashion in a Cognitive Behavioral Neurology Unit, and the gold standard diagnosis was established by consensus of
expert neurologists on the basis of these results. Effectiveness of tests was assessed as the proportion of correct diagnoses
(diagnostic accuracy [DA]) and the kappa index of concordance (k) with respect to gold standard diagnoses. Costs were
based on public prices at the time and hospital accounts.
Results: The study included 139 individuals: 47 with DEM, 36 with CI, and 56 without CI. No significant differences in
effectiveness were found among the tests. For DEM screening: Eurotest (k=0.71 [0.59–0.83], DA=0.87 [0.80–0.92]), M@T
(k=0.72 [0.60–0.84], DA=0.87 [0.80–0.92]), Phototest (k=0.70 [0.57–0.82], DA=0.86 [0.79–0.91]). For CI screening: Eurotest
(k=0.67 [0.55–0.79]; DA=0.83 [0.76–0.89]), M@T (k=0.52 [0.37–0.67]; DA=0.80 [0.72–0.86]), Phototest (k=0.59 [0.46–0.72];
DA=0.79 [0.71–0.86]). There were no differences in the cost of DEM screening, but the cost of CI screening was significantly
higher with M@T (330.76177.1J, mean6sd) than with Eurotest (294.16195.0J) or Phototest (296.06196.5J). Application
time was shorter with Phototest (2.860.8 min) than with Eurotest (7.161.8 min) or M@T (6.862.2 min).
Conclusions: Eurotest, M@T, and Phototest are equally effective. Eurotest and Phototest are both less expensive options but
Phototest is the most efficient, requiring the shortest application time.
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Introduction
Short cognitive tests (SCTs) are routinely applied by healthcare
professionals in different settings. SCTs are usually associated with
screening for cognitive impairment (CI) and dementia (DEM) and
are also used to assess the response to treatment and to follow up
this type of patient. Their results sometimes serve as criteria for
access to studies, treatments, and disability benefits, among others.
Some of the most widely used SCTs, such as the Memory Impairment
Screen [1] and Addenbrooke’s Cognitive Examination [2], include tasks that
require reading and writing ability and cannot be used on illiterates.
Other tests, including the Clock-Drawing Test [3], General Practitioner
Assessment of Cognition [4], Mini-Cog [5], Montreal Cognitive Assessment [6],
Seven Minute Test [7], and Rowland Universal Dementia Assessment Scale[8],
do not require reading or writing but involve the use of pencil and
paper, which can generate aversion among illiterates and individuals
of low educational level. The most frequently applied test, the Mini-
MentalState Examination(MMSE) [9], has both types of item, making it
especially unsuitable. In fact, its low validity and diagnostic accuracy
in populations with a low educational level has been demonstrated by
our group [10] and other authors [11,12]. Educational factors are
known to exert an important influence on MMSE results [13,14],
leading some authors to advise against its use in less-educated
populations [15,16].
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estimated to be illiterate[17], in developed as well as developing
nations. In the USA, 3% of adults (7 million) are illiterate [18].
Account must also be taken of the emergence of ‘‘relative
illiteracy’’, i.e., the inability of people literate in their own
languages to read or write in the language of their host country.
This phenomenon is on the increase, due to rises in emigration
and tourism. Instruments requiring the ability to read cannot be
used on people in this situation, considered to represent 2% of the
USA population, around four million individuals [18].
Furthermore, CI and DEM are increasing in developing
countries [19], where illiteracy is more widespread, underscoring
the need for tests that do not need reading or writing skills or the
use of pencil and paper, allowing whole populations to be
evaluated with the same instruments.
The Short Portable Mental Status Questionnaire [20] and Abbreviated
Mental Test [21] can be applied to an individual who is not literate
and do not require pencil and paper, but they are of limited
usefulness to detect CI. The Leganes Cognitive Test [22] and the
Community Screening Interview for Dementia (CSI-D) [23], whose use
was proposed by the 10/66 group [24], also have these illiterate-
friendly characteristics, although they take too long to apply
(.10 min) given the time constraints on Primary Care (PC)
consultations [25].
Three new SCTs with none of these limitations are increasingly
used in our country (Spain), in which more than 10% of the
population aged over 65 years is illiterate due to particular historical
circumstances [26]. One is the Eurotest [27] (www.eurotest.es),
which evaluates knowledge and use of the local currency and
includes an episodic memory test. Its results are not influenced by
educational level, and it has proven to be a reliable and ecologically
valid instrument [28]; it takes around 7 minutes to apply and yields
information on the functional capacity and autonomy of the testee.
Its discriminant validity for CI and DEM has been confirmed in
various studies, including a meta-analysis [29,30,31,32]. It can be
used without any modification in all countries of the Eurozone and
can be readily adapted to other official currencies [33].
Another of these recent SCTs, the Memory Alteration Test
(M@T) [34], was designed for the early detection of Alzheimer’s
Disease, including prodromal stages [35], and it evaluates
temporal orientation and different types of memory (episodic,
textual, and semantic). It takes 5–6 minutes to apply and has a
high internal consistency and validity, although no data are
available on its reliability. Its results are mildly influenced by
educational level, and distinct cutoff points according to years of
schooling are recommended when used for CI screening (36/37 if
,8 years; 37/38 if .8 years).
Finally, the Phototest [36] (www.fototest.es) is a very simple and
short instrument (,3 min) that assesses naming, verbal fluency
(people’s names [37]), and episodic memory. Its results are
normally distributed and are not influenced by educational level
[38]. It has good test-retest and inter-observer reliability [38], and
various studies have demonstrated that the cut-off points 26/27
and 28/29 offer adequate discriminant validity for DEM and CI,
respectively [10,31,36,39].
These three instruments differ widely in structure and
application requirements but are all short, applicable to illiterates,
performed without paper or pencil, and validated for CI (Table 1).
The objective of this study was to compare the diagnostic
accuracy, effectiveness and costs of DEM and CI screening with
the use of these tests.
Methods
Ethics Statement
The study was approved by the Ethics and Research Committee
of the Virgen de las Nieves University Hospital (Granada, Spain),
and written informed consent was obtained from all participants or
their carers.
Design
This prospective and naturalistic Phase III study of diagnostic
test assessment [40] had a paired design (all tests applied to all
participants) and complete verification (all participants underwent
the standard diagnostic procedure) [41].
Setting
Four PC centers in the Metropolitan District of North Granada
Area (Southern Spain).
Study population
Consecutive patients attended in PC centers from February 1
2008 to January 31 2009 with suspicion of CI or DEM based on
observations of healthcare professionals or reports of memory or
cognitive impairment problems by patient, family member, or a
third party. Exclusion criteria were absence or withdrawal of
consent, previous enrolment in this study, or previous diagnosis of
CI or DEM. There were no age limits. Sensory or motor deficits or
other prior conditions were not reasons for exclusion.
Procedure
The Eurotest, M@T, and Phototest were applied in a balanced
manner to all participants. Regardless of their test results, all
subsequently visited the Cognitive Behavioral Neurology Unit
(CBNU) of the Neurology Department of Virgen de las Nieves
University Hospital, Granada for a complete assessment, including
clinical examination and behavioral testing (Spanish adaptation of
the Neuropsychiatric Inventory Questionnaire [42]), functional testing
(Barthel Index [43], Lawton-Brody scale [44] and Functional Activities
Questionnaire [45]), and a detailed neuropsychological examination
Table 1. Characteristics of the short cognitive tests.
Structure Instrumentation Cut-off point
Test T O M F N C RS Other DEM CI
Eurotest 5–10 X X X Coins 20/21 22/23
M@T 5–10 X X X 28/29 36/37&37/38*
Phototest ,5 X X X X Laminated sheet 26/27 28/29
M@ T: Memory Alteration Test. T: time in minutes. O: orientation; M: memory; F: verbal fluency; N: naming; C: calculation. RS: record sheet. DEM: dementia; CI: cognitive
impairment. *36/37 for individuals without and 37/38 for those with primary schooling.
doi:10.1371/journal.pone.0027069.t001
Short Cognitive Tests for Illiterates
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function (similarities, verbal fluency), memory (learning, deferred
recall and recognition), language (naming, comprehension,
fluency), visual-spatial functions [drawing, copying], calculation,
and motor praxis. Two neurologists with experience in cognitive-
behavioral neurology established the gold standard diagnosis by
consensus, based on the CBNU evaluations, classifying individuals
as: Non-CI (NoCI), CI non-DEM (CInD) (criteria for mild CI of
the Neurology of Behavior and Dementias Study Group of the
Spanish Neurology Society [46]) or DEM (DSM-IVR criteria)
[47]. Any lack of consensus was resolved by the decision of a third
neurologist. All three experts were blinded to the screening test
results.
Statistical analysis
The effectiveness of the screening tests was evaluated by
analyzing the diagnostic accuracy (DA, proportion of correct
diagnoses) and the kappa index of diagnostic concordance (k) with
respect to the gold standard diagnosis (positive/negative),
considering the cutoff points recommended by the authors
(Table 1) [48]. Effectiveness was calculated for DEM versus non-
DEM (NoCI+CInD) and for CI (DEM+CInD) versus NoCI.
The cost analysis was based on the perspective of our healthcare
organization and took no account of the direct costs of patients/
carers, indirect or intangible costs, or the economic effects of
diagnostic delay due to false negatives. For each test, we considered
the minimum costs required to reach the correct diagnosis for each
condition. Hence, in the usual clinical situation, true negatives
would only incur the cost of the PC consultation (43.5J), whereas
true positives and false positives would also incur the costs of the
CBNU study (neurologist, neuropsychologist, nurse: 197.4J) and of
the minimum complementary tests recommended by the Spanish
Neurology Society (analytical, cranial CT-scan: 193.4J), a total of
390.8J. For their part, false negatives would require at least one
more PC consultation besides the initial evaluation, as well as the
CBNU study. The cost of the PC consultation was taken from
published rates and prices of the Andalusian public healthcare
system (Order of October 14 2005), and the cost of the CBNU
evaluation was based on the hospital’s financial accounts (Table 2).
SPSS version 15.0 (SPSS Inc., Chicago, IL) was used for the
data analyses. Qualitative variables were compared among groups
by means of the chi-square test or comparison of proportions, and
quantitative variables were compared with an ANOVA, applying
the Bonferroni test in post-hoc analyses. Time intervals and costs
were compared with a t-test for related samples. P,0.05 was
considered significant, and 95% confidence intervals were
calculated for all study variables.
Formal aspects
The study design and report writing complied with STARD
recommendations for diagnostic test studies [41] and the Food and
Drug Administration guidelines for reporting diagnostic study
results [49].
Results
The four health centers in the study serve a population of
66,713 people, of whom around 16.7% are $65 years old [26].
During the study period, PC physicians reported suspicion of CI or
DEM in 156 patients, based on complaints by the patients
themselves in 70 cases (44.9%) and by a relative or third party in
76 cases (48.7%) or on initial observations by the physicians in the
remaining 10 cases (6.4%). Out of these 156 patients, 17 did not
complete the study: 5 refused or withdrew consent, 4 were lost to
the follow up, 1 was excluded for protocol violation, and 7 were
not fully evaluated, due to sequelae of stroke or traumatic brain
injury associated or not with sensory deficit (amaurosis, cophosis)
or recording error. Out of the 139 patients completing the study,
47 (33.8%) had DEM, 36 (25.9%) CI without DEM (CInD), and
56 (40.3%) had neither CI nor DEM (NoCI) (figure 1).
Table 3 shows the socio-demographic characteristics and
screening test results of the participants, stratified by cognitive
Table 2. Minimum costs per diagnosis.
PC study CBNU study Total
Diagnoses 43.5J 390.8J (J)
True Negative 1 - 43.5
True Positive 1 1 434.4
False Positive 1 1 434.4
False Negative 2 1 477.9
PC: Primary Care; CBNU: Cognitive Behavioral Neurology Unit.
doi:10.1371/journal.pone.0027069.t002
Figure 1. Study flow chart. PC: Primary Care; CBNU: Cognitive
Behavioral Neurology Unit; DEM: dementia. CInD: cognitive impairment
without dementia; NoCI: no cognitive impairment.
doi:10.1371/journal.pone.0027069.g001
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female. More than half (50.4%) had not completed primary
schooling, and 14.4% of these were not literate. There were no
significant gender differences among diagnostic groups, but subjects
with DEM were older and had a lower educational level than those
with CInD or NoCI (p,0.001 for all comparisons). The groups
significantly differed in test results in the order NoCI.CInD.-
DEM (p,0.001 for all comparisons). The time taken to complete
the test did not significantly differ (p=0.06) between Eurotest
(7.161.8 min) and M@T (6.862.2 min) but was significantly lower
(p,0.001) for Phototest (2.860.8 min) than for either.
All three tests showed very high and similar DA values for DEM
(table 4): 0.86 (95% confidence interval [95%CI], 0.79–0.91) for
Phototest and Eurotest and 0.87 (95%CI, 0.80 – 0.92) for M@T,
with no significant difference among them (p=0.94). Diagnostic
concordance values were also substantial [50] and practically
identical for DEM: 0.70 (95%CI, 0.57 – 0.82) for Phototest, 0.71
(95%CI, 0.59 – 0.83) for Eurotest, and 0.72 (95%CI, 0.60 – 0.84)
for M@T (p=0.97). For DEM, the instruments did not
significantly differ in mean associated costs: 206.66196.6J for
Phototest, 221.36196.0J for M@T, and 221.66196.4J for
Eurotest (p.0.05, all comparisons).
All three tests had a lower predictive value for CI than for DEM
(table 5). For CI, no significant differences were found among the
tests, with slightly but not significantly superior results for Eurotest
(k=0.67 [95%CI, 0.55 – 0.79]; DA=0.83 [95%CI, 0.76 – 0.89])
versus M@T (k=0.55 [95%CI, 0.43– 0.71]; DA=0.73 [95%CI, 0.64
– 0.80]) and Phototest (k=0.59 [95%CI, 0.46 – 0.72]; DA=0.79
[95%CI, 0.71 – 0.86]). For CI, mean associated costs did not
significantly differ between Eurotest and Phototest (294.16195.0J
vs. 296.06196.5J; p=0.79) but were significantly higher with M@T
(330.76177.1J)t h a nw i t hE u r o t e s t( p ,0.001) or Phototest (p,0.01).
Discussion
In this study of diagnostic test assessment in an urban population
with a low educational level, all three SCTs evaluated showed a
similar and substantial effectiveness [50], correctly classifying around
85% of the sample for DEM and 80% for CI. The instruments did
not differ in mean associated costs in relation to DEM detection,
while the cost ofM@Tfor CI was slightly higher thanthat ofEurotest
and Phototest, probably attributable to its lesser specificity, i.e., larger
number of falsepositives. An important finding was that the Phototest
is completed in half the time (,3 min) required by the other two tests
(<7 min), a significant and clinically relevant difference.
Our results are highly similar to those of individual studies of these
instruments. In a meta-analysis, Eurotest [32] was found to correctly
classify 85% of patients for DEM, virtually identical to the percentage
(87%) in the present study and using t h es a m ec u t - o f fv a l u e( 2 0 / 2 1 ) .
The Phototest results for each diagnosis (34.565.0 NoCI, 30.464.8
CInD, 21.465.5 DEM) did not significantly differ from results
obtained with the Phototest in a multi-center study using the same
diagnostic criteria (33.164.8, 28,964.8 and 19,966.8, respectively)
[39]. The mean M@T score of the present CInD group (31.268.3) is
virtuallyidentical to that ofthegroup with mildCI(the onlydiagnosis
with a comparable definition) in the original M@T study (31.563.9),
Table 3. Socio-demographic characteristics and screening test results by diagnostic group.
Total CI NoCI CInD DEM NoDEM
(n=139) (n=83) (n=56) (n=36) (n=47) (n=92)
Age years 72.0611.5 77.167.5 64.6612.2 74.367.3 79.367.0 68.4611.6
Sex female 101 (72.7) 59 (71.1) 42 (75.0) 22 (61.1) 37 (78.7) 64 (69.6)
male 28 (28.3) 24 (29.9) 15 (25.0) 14 (38.9) 10 (21.3) 28 (30.3)
Educational level Illiterate 20 (14.4) 19 (22.9) 1 (1.8) 3 (8.3) 16 (34.0) 4 (4.3)
,Primary 50 (36.0) 33 (39.8) 17 (30.4) 15 (41.7) 18 (38.3) 32 (34.8)
$Primary 69 (49.6) 31 (37.3) 38 (67.9) 18 (50.0) 13 (27.7) 56 (60.9)
Eurotest Score 20.4610.2 14.969.2 28.564.5 22.666.4 9.066.3 26.266.0
time (min) 7.161.8 7.761.5 6.361.9 7.761.7 7.861.3 6.862.0
Phototest Score 29.067.7 25.366.9 34.565.0 30.464.8 21.465.5 32.965.4
time (min) 2.860.8 2.960.8 2.560.7 2.560.5 3.260.9 2.560.6
M@T Score 29.0612.5 22.2611.0 39.266.0 31.268.3 15.367.3 36.168.0
time (min) 6.862.2 7.662.0 5.661.9 6.661.5 8.461.9 6.061.8
CI: cognitive impairment (CInD+DEM). NoCI: no cognitive impairment. CInD: cognitive impairment without dementia. DEM: dementia. NoDEM: no dementia
(NoCI+CInD). M@T: Memory Alteration Test. Data are nu individuals (percentage) or mean6sd.
doi:10.1371/journal.pone.0027069.t003
Table 4. Effectiveness and cost for dementia.
Test CuP TP TN FP FN DA k Mean cost (J)
Eurotest 20/21 44 76 16 3 0.86 (0.79–0.91) 0.71 (0.59–0.83) 221.66196.4
M@T 28/29 45 76 16 2 0.87 (0.80–0.92) 0.72 (0.60–0.84) 221.36196.0
Phototest 26/27 38 82 10 9 0.86 (0.79–0.91) 0.70 (0.57–0.82) 206.66196.6
M@T: Memory Alteration Test. CuP: cutoff point; TP: true positives; TN: true negatives; FP: false positives; FN: false negatives; DA: diagnostic accuracy (proportion of
correct diagnoses); k: kappa ı ´ndex. In parentheses: 95% confidence interval. Mean cost: mean6sd.
doi:10.1371/journal.pone.0027069.t004
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percentage obtained in the present study (78%) [34].
A recent secondary analysis of studies by the 10/66 Dementia
ResearchGroupreportedthatashortenedversionoftheCSI-Dtakes
around five minutes to apply and offers the same diagnostic
performance as the complete version of this instrument [51]. Youden
index (sensitivity-[1-specificity]) scores for DEM ranged from 0.63 to
0.75 in all study groups except for one in Nigeria (0.92) [51]; these
results, which have not yet been verified in a prospective study in the
clinical setting, are very similar to the those obtained with each test in
the present study (Eurotest 0.77, M@T 0.79, Fototest 0.70).
To our best knowledge, this is the first study of SCTs that
evaluates the associated costs. Although not strictly a cost-
effectiveness analysis [52], our report on the differences among
these tests canserve as a guide for decision-making inthe interests of
maximizing efficiency. We did not takeaccount of the material costs
of applying the tests, on the assumption that they use an equal and
minimal amount of resources, requiring just one sheet of paper plus
a laminated sheet for Phototest and a set of coins for Eurotest
(Table 1), which can both be reutilized. It should also be borne in
mind that we adopted the perspective of our public health system,
which is free to users. With regard to the key resource of time, all
three are reasonably short, but Phototest needs only 3 minutes, less
than half the time taken to apply Eurotest or M@T and highly
suited to the usual time restrictions for a PC consultancy [25].
Phototest meets all recommended conditions to be utilized in
PC [53], including: the favorable cost-effectiveness results found in
this prospective study in the PC setting, the ease of its application
[36], brevity (,3 min), and superior diagnostic usefulness in
comparison to MMSE [10].
The main strength of this diagnostic test evaluation is its naturalistic
and pragmatic nature, given that it wasp r o s p e c t i v e l yp e r f o r m e di nt h e
care setting in which the diagnostic problem arises, with a sufficiently
long study period to avoid any seasonal variations. Moreover, the
recruitment was consecutive and systematic, with minimal exclusion
criteria. Consequently, our sample offers a faithful reflection of the
diagnostic problem routinely faced in this care setting, yielding robust
results that estimate the effectiveness rather than just the efficacy of
these instruments. In addition, the main biases found in diagnostic test
evaluations [40,54] were minimized by evaluating all participants with
all three tests and subjecting all to the gold standard diagnostic
procedure, regardless of their screening test results.
One study limitation was the lack of a comparative analysis
among diagnostic subgroups. A further potential weakness was the
serial application of the tests, which may have produced biases due
to fatigue, despite their short nature. To address this possibility, we
applied the tests in a balanced manner, finding that the results were
not affected by the order in which a test was taken (data not shown).
In conclusion, our results demonstrate that Eurotest, M@T and
Phototest are equally effective instruments for DEM and CI
screening in the PC setting. The cost of each test was similar for
DEM identification, while the cost of M@T was slightly higher for
CI screening. Phototest was applied in half the time required by
the other two tests, a statistically significant and clinically relevant
finding, establishing Phototest as the most efficient option and
especially suitable for utilization in PC.
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